However, these differences did not reach statistical significance in the primary analysis.
← all excerpts
Postoperative immune checkpoint inhibitors plus anti-angiogenesis for hepatitis B virus-associated hepatocellular carcinoma: Analyzing the evidence and future prospects.
1
—
—